第53回日本免疫学会学術集会

^○Keiko Yasuda^1,2, Junichi Aoki¹, Kotaro Tanaka¹, Daiya Ohara³, Keiji Hirota³, Osamu Takeuchi¹ (1.Department of Medical Chemistry, Graduate School of Medicine, Kyoto University, 2.Department of Immunology, Nagoya City University Graduate School of Medical Sciences, 3.Laboratory of Integrative Biological Science, Institute for Life and Medical Sciences, Kyoto University)

^○Ryutaro Furukawa¹, Noriko Ouji-Sageshima¹, Masahiro Kitabatake¹, Atsushi Hara¹, Shigeyuki Shichino², Satoshi Ueha², Kouji Matsushima², Toshihiro Ito¹ (1.Department of Immunology, Nara Medical University, 2.Division of Molecular Regulation of Inflammatory and Immune Diseases, Research Institute for Biomedical Sciences, Tokyo University of Science)

^○Tomohiro Takano¹, Keigo Kumagai², Hitoshi Iuchi³, Aya Mizuike^2,4, Tomoharu Mizukami², Eita Sasaki¹, Koji Kobiyama⁵, Ken Ishii⁵, Michiaki Hamada³, Masayoshi Fukasawa², Takayuki Matsumura¹, Yoshimasa Takahashi¹ (1.Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, 2.Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases, 3.Faculty of Science and Engineering, Waseda University, 4.Center for Quality Management Systems, National Institute of Infectious Diseases, 5.The Institute of Medical Science, The University of Tokyo)

^○Mizuki Fujisawa¹, Takayuki Matsumura¹, Saya Moriyama¹, Yu Adachi¹, Ryutaro Kotaki¹, Tomohiro Takano¹, Masaharu Shinkai², Yoshimasa Takahashi¹ (1.Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, 2.Tokyo Shinagawa Hospital)

^○Chieko Makino Okamura^1,2, Tianchen Zhao^3,4, Yuta Tani³, Morihito Takita^3,4, Chika Yamamoto^3,4, Hiroki Yoshimura^3,4, Harumichi ishigame^1,5, Takaharu Ueno⁶, Kazu Okuma⁶, Masatoshi Wakui⁷, Masaharu Tsubokura^3,4, Hidehiro Fukuyama^1,2,8,9 (1.Division of Immunology, Near InfraRed Photo-ImmunoTherapy Research Institute, Kansai Medical University, 2.Infectious Diseases Research Unit, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa, Japan, 3.General Incorporated Association for Comprehensive Disaster Health Management Research Institute, Tokyo, Japan, 4.Department of Radiation Health Management, Fukushima Medical University School of Medicine, Fukushima, Japan, 5.Laboratory for Tissue Dynamics, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa, Japan, 6.Department of Microbiology, Kansai Medical University, School of Medicine, Hirakata, Osaka, Japan, 7.Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan, 8.Cell Integrative Science Laboratory, Graduate School of Medical Life Science, Yokohama City University, Yokohama, Kanagawa, Japan, 9.INSERM EST, Strasbourg, France)

^○Tingyu Gao, Atsushi Irie, Takahisa Kouwaki, Hiroyuki Oshiumi (Dep Immunol, Grad Sch Med Sci, Kumamoto University)

^○Dongyun Lu¹, Celine Chua¹, Xinxin Xue¹, Naila Shinwari¹, Ito Isao², Takao Hashiguchi³, Ryutaro Kotaki⁴, Yoshimasa Takahashi⁴, Hideki Ueno¹ (1.Department of Immunology, Graduate School of Medicine, Kyoto University, 2.Department of Respiratory Medicine, Kyoto University Hospital, 3.Institute for Frontier Life and Medical Sciences, Kyoto University, 4.Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases)

^○Kohei Kometani¹, Takaaki Yorimitsu^1,2, Norihide Jo^1,3, Yoko Hamazaki^1,4,5 (1.Department of Life Science Frontiers, Center for iPS Cell Research and Application (CiRA), Kyoto University, 2.Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, 3.Alliance Laboratory for Advanced Medical Research, Graduate School of Medicine, Kyoto University, 4.Laboratory of Immunobiology, Graduate School of Medicine, Kyoto University, 5.Kyoto University Immunomonitoring Center (KIC))

^○Takuto Nogimori¹, Mayu Kumamoto^1,2, Yuji Masuta¹, Tomoka Matsuura³, Satoko Ohfuji³, Tetsuo Kase³, Kyoko Kondo⁴, Yu Nakagama⁵, Yasutoshi Kido⁵, Victor Appay⁶, Wakaba Fukushima³, Takuya Yamamoto^1,2,7 (1.Laboratory of Precision Immunology, Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health, and Nutrition, Osaka 567-0085, Japan, 2.Laboratory of Aging and Immune Regulation, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan, 3.Department of Public Health, Graduate School of Medicine, Osaka Metropolitan University, Osaka, 545-8585, Japan, 4.Management Bureau, Osaka Metropolitan University Hospital, Osaka, 545-8585, Japan, 5.Department of Virology and Parasitology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, 545-8585, Japan, 6.Université de Bordeaux, CNRS UMR 5164, INSERM ERL 1303, ImmunoConcEpT, 33000 Bordeaux, France, 7.Department of Virology and Immunology, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan)

^○Chihiro Motozono¹, Mako Toyoda¹, Hiroshi Hamana², Hiroyuki Kishi², Takamasa Ueno¹ (1.Kumamoto University, Joint Research Center for Human Retrovirus infection, 2.University of Toyama, Department of Immunology, Faculty of Medicine, Academic Assembly)

^○Koubun Yasuda¹, Miya Fujimoto², Etsushi Kuroda¹ (1.Department of Immunology, School of Medicine, Hyogo Medical University, 2.Menicon Co., Ltd)

^○Ryuta Uraki^1,2,3, Maki Kiso³, Mutsumi Ito², Seiya Yamayoshi^1,2,3, Peter Halfmann⁴, Shilpi Jain^5,6,7, Mehul S. Suthar^5,6,7,8, Nao Jounai⁹, Kazuki Miyaji⁹, Fumihiko Takeshita⁹, Yoshihiro Kawaoka^1,2,3,4 (1.National Center for Global Health and Medicine, 2.Division of Virology, Institute of Medical Science, The University of Tokyo, 3.The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (The UTOPIA Center), 4.Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, 5.Department of Pediatrics, Emory University School of Medicine, 6.Emory Vaccine Center, 7.Emory National Primate Research Center, 8.Department of Microbiology and Immunology, Emory University, 9.Vaccine Research Laboratories, R&D Division, Daiichi Sankyo Co., Ltd.)

^○Yuko Nariai¹, Toru Katsumata², Takashi Nakai^1,2, Tsuyoshi Shimoboji², Takeshi Urano¹ (1.Vaccine and Therapeutic Antibodies for Emerging Infectious Diseases,Shimane University, 2.Asahi Kasei Corporation, Life Innovation Business Division, Healthcare Materials Division, New Product Development Office)

^○Yu-Chen Liu^1,2 (1.Laboratory for Human Immunology (Single Cell Genomics), WPI Immunology Frontier Research Center, Osaka University, 2.Center for Infectious Disease Education and Research (CiDER), Osaka University, Osaka, Japan.)

^○Kosuke Miyauchi, Akiko Sugimoto, Takashi Watanabe (RIKEN IMS)

^○Kazuko Uno¹, Abu Hasan², Rummana Rahim², Toshio Tanaka³, Mizanur Rahman², Kazuyuki Yoshizaki⁴ (1.IFN & Host-defense Research Laboratory, Louis Pasteur Center for Medical Research, 2.Evercare Hospital Dhaka, 3.Kinki Central Hospital, 4.Department of Organic Fine Chemicals, Institute of Scientific and Industry Research, Osaka University)

^○Masahiro Kiuchi¹, Chiaki Iwamura^1,2, Kaori Tsuji¹, Atsushi Sasaki¹, Takahisa Hishiya¹, Rui Hirasawa¹, Kota Kokubo¹, Atushi Onodera¹, Motoko Kimura^2,3, Shinichiro Motohashi⁴, Kiyoshi Hirahara^1,2,5 (1.Department of Immunology, Graduate School of Medicine, Chiba University, 2.Synergy Institute for Futuristic Mucosal Vaccine Research and Development, Chiba University, 3.Department of Experimental Immunology, Graduate School of Medicine, Chiba University, 4.Department of Medical Immunology, Graduate School of Medicine, Chiba University, 5.AMED-CREST)

Eleonor F Avenido-Cervantes^1,2, Akiko Baba¹, Jiun-Yu Jian³, Archival M Cervantes², Blanca R Jarilla-Nagataki², Mario Antonio L Jiz II², Arthur Dessi E Roman⁴, Yu-Chen James Liu⁵, Daisuke Okuzaki⁵, Shusaku Mizukami³, Katsuyuki Yui³, ^○kenji Hirayama¹ (1.School of Tropical medicine and Global Health and NEKKEN, Nagasaki University, 2.Immunology Department, Research Institute for Tropical Medicine, Philippines, 3.Department of Immune regulation, Institute of Tropical Medicine (NEKKEN), Nagasaki University, 4.Clinical Research Division, Research Institute for Tropical Medicine, Philippines, 5.Human Immunology (Single Cell Genomics), Immunology Frontier Research Center: IFReC, Osaka University)

^○Risako Kanemitsu¹, Yu Miyamoto^2,3, Masaru Ishii^1,2,3 (1.Department of Immunology and Cell Biology, Graduate School of Frontier Biosciences, Osaka University, Osaka, Japan, 2.Department of Immunology and Cell Biology, Graduate School of Medicine, Osaka University, Osaka, Japan, 3.WPI-Immunology Frontier Research Center, Osaka University, Osaka, Japan)

^○Ayumi Okuzumi¹, Kazuyo Moro^1,2,3 (1.Laboratory for Innate Immune Systems, Graduate School of Medicine, Osaka University, 2.Laboratory for Innate Immune Systems, RIKEN-IMS, 3.Laboratory for Innate Immune Systems, iFReC, Osaka University)

^○Rosinta Hotmaida Pebrianti Purba¹, Lintong Hottua Simbolon¹, Helen Try Juniasti^2,1 (1.Department of Socioeconomics and Health Research, The Pranala Institute, Indonesia, 2.Department of Public Health, Cendrawsih University, Indonesia)